ReviewFrontiers in medicine2020
Predicting Response to Vedolizumab in Inflammatory Bowel Disease.
Joseph Meserve et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this paperpooled itcites it
ReviewFrontiers in medicine2020
Joseph Meserve et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.